Home > Healthcare > Medical Devices > Therapeutic Devices > Proton Therapy Systems Market

Proton Therapy Systems Market Size

  • Report ID: GMI6685
  • Published Date: Sep 2023
  • Report Format: PDF

Proton Therapy Systems Market Size

Proton Therapy Systems Market was valued at USD 1.2 billion in 2022 and is estimated to account for USD 3.2 billion by 2032.

 

Cancer is a major health concern worldwide, and its prevalence is increasing at an alarming rate. The World Cancer Research Fund International estimated that approximately 19 million new cancer cases were registered in 2021, and this number is anticipated to increase to 24 million by 2035, globally. Moreover, according to the American Cancer Society, around 1.9 million new cases of cancer were diagnosed in the U.S. alone in 2021. Thus, rise in the number of cancer cases is one of the major drivers of growth in the market.

 

The growing demand for non-invasive cancer treatment options is driving the growth of the proton therapy systems market. Proton therapy is a non-invasive treatment option that delivers high doses of radiation to cancer cells while minimizing damage to surrounding healthy tissues. This makes it a striking option for patients that want to avoid the side effects associated with traditional cancer treatments such as chemotherapy and surgery. Various other advantages associated with proton therapy systems, such as high precision and radiation control, reduced risk of side effects, and minimal exposure of normal tissues to radiation, make it the most suitable treatment option for pediatric cancer cases especially. Thus, these factors are considered as major factors leading the market industry.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Proton therapy systems industry size was USD 1.2 billion in 2022 and will reach USD 3.2 billion by 2032 due to the increasing prevalence of cancer cases worldwide.

Proton therapy systems industry from the gastro-intestinal cancer application segment reached USD 322 million in 2022 on account of its prevalence as the third most diagnosed cancer globally.

U.S. proton therapy systems industry size registered USD 530 million in 2022 and is expected to witness appreciable growth from 2023-2032 owing to clinical advantages, broader recognition, and investments in infrastructure and research in the region.

IBA worldwide, Hitachi, Mevion Medical Systems, Optivus Proton Therapy, Advanced Oncotherapy plc, Mitsubishi Electric Corporation, Varian, Ion Beam Applications SA, ProTom International, and Provision Healthcare are some of the major proton therapy system companies worldwide.

Proton Therapy Systems Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 261
  • Countries covered: 30
  • Pages: 150
 Download Free Sample